Fobi Signs Agreement With Empower Clinics To Fully Integrate Empower Clinic’s Kai Care Client Testing Data Base

By AIT News Desk On Oct 12, 2021

Fobi AI, a leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement, is pleased to announce the Company has entered into a Service Agreement with Empower Clinics Inc. to integrate Fobi’s artificial Intelligence data applications and wallet pass platform into Empower’s Kai Care COVID-19 Testing product.

Fobi Agreement Supports Empower’s Goal of Becoming A Cutting Edge Health Care Provider and Innovator.

The Service agreement involves the integration of Fobi’s Wallet pass platform into the Kai Care COVID-19 testing product and back-end lab management system, which will create a much more secure and seamless next level of digital customer experience for not only COVID-19 tests, receiving results and providing verification of a negative Covid test, but for all other future testing applications as well. As part of the Kai Care testing process, all customers will now have the ability to download a Kai Care Wallet pass directly into the native wallet that lives in all Apple & Android mobile phones. The Kai Care Pass will then be used for delivering test results direct to the mobile wallet in a safe and secure format. The new digital offering is very well timed given various international government mandates in regards to digital health passport requirements with proof of vaccinations and negative Covid test requirements.

Empower To Leverage Fobi Ai Artificial Intelligence To Deliver Kai Care Clients Personalized Client Experience Which Provides Untapped And Potential New Line Revenue Opportunities.

The Kai Care Wallet pass can also be used by Empower as a new customer engagement channel. User adoption and retention of Wallet passes is much higher than normal mobile phone Apps, and campaigns for additional Kai Labs tests or relevant 3rd party products or services can be pushed out to their customers through banner ads on the front of the Wallet pass, links on the back of the Wallet pass, or through push notifications to customer mobile phone lock screens. The new integrated solution also has a very high level of data security, with Fobi’s Wallet pass powered by Hedera Hashgraph. This new engagement channel also opens up potentially new advertising and data monetization options for both Empower and Fobi. In particular, Empower can now use the Wallet pass to promote and monetize products such as their own new testing products, as well as other 3rd party products such as travel insurance, etc. Under the terms of the agreement, Fobi will receive revenue for each Wallet pass downloaded and Fobi and Empower will split the proceeds of any new advertising or data monetization revenue opportunities realized from this service agreement.

Bureau Raises $30Million Series B as Global Fraud Losses Hit $486 Billion

Dec 19, 2024

Run:ai to Streamline the Deployment and Management of AI Infrastructure for Enterprises

Dec 19, 2024

EQTY Lab, Intel, and NVIDIA Unveil ‘Verifiable Compute,’ A Solution to Secure Trusted AI

Dec 19, 2024

Prev Next 1 of 40,854

Empower CEO Steven McAuley stated: “Testing and vaccinations are becoming a pillar of everyday life as society continues its fight against COVID-19. I’m proud to deepen our relationship with Fobi and meet the massive demand for reliable, secure and easy COVID-19 testing results and verification sharing. By working together our companies are supporting a safe reopening for individuals, businesses, schools, and so much more.”

This service agreement builds upon the relationship between Fobi (previously Loop Insights) and Empower that was announced in October 2020. Since then, Empower Clinics have released their own E-Commerce site and signed major distribution deals with several pharmacies and retail outlets across North America to stock Kai Care testing kits on their shelves. Empower are expecting additional distribution deals to be signed in the near future, which will increase the number of kits sold and customers worldwide, which management believes bodes well for revenue projections for both Empower and Fobi.

A recent report from Grandview Research shows the COVID-19 Antigen Testing Market size will grow at a CAGR of 6.7% from 2021 and will reach USD $8.3 Billion by 2027. With Fobi’s Wallet pass platform enabling an even more secure and seamless customer experience for Covid testing and result verification, it is anticipated that Empower will increase their share of that market significantly.

Fobi CEO Rob Anson stated: “Powering the Kai Care Wallet pass and supporting Empower to leverage our artificial intelligence data applications clearly provides Empower Clinics and Kai Care with a clear product differentiator in the testing marketplace. There are other testing providers out there, but none of which offer real time results delivered directly to the wallet. The Kai Care Wallet pass solution will provide the means to deliver a new level of personalized client engagement, scheduling and messaging. This new product release also provides Empower and Fobi with the ability to generate additional revenue through the data and advertising monetization opportunities. We are very excited to continue our support of our strong partnership with Empower Clinics.”

[To share your insights with us, please write to sghosh@martechseries.com]